About
HitGen is a drug discovery company based in Chengdu, China, with subsidiaries in Cambridge, UK, and Houston, USA. It serves pharmaceutical and biotechnology companies, chemical firms, foundations, and research institutions with DEL-based discovery, chemistry, biology, and preclinical services.
Services
DNA Encoded Library design and synthesis
Designs and synthesizes DNA-encoded compound libraries for discovery and optimization programs.
DNA Encoded Library screening
Uses DEL screening to identify small-molecule ligands for challenging targets.
OpenDEL
Provides OpenDEL-enabled DEL discovery services as part of the company’s screening platform.
Nucleic acid sequence design
Designs nucleic acid sequences to support oligonucleotide-based projects.
Monomer and solid support chemistry
Provides chemistry support for monomers and solid supports used in nucleic acid and library work.
Oligonucleotide chemistry
Supports oligonucleotide-related chemistry and conjugation work.
Nucleic acid delivery
Develops conjugates and related chemistry for nucleic acid delivery applications.
CDMO
Provides contract development and manufacturing services within its integrated discovery platform.
20 more services
- Protein degradation
- E3 ligases and their binders
- Discovery of molecular glue degraders
- Discovery of proteolysis-targeting chimeras (PROTACs)
- Protein degrader evaluation
- High throughput chemistry
- Synthetic chemistry
- Peptide chemistry
- Medicinal chemistry
- Process chemistry
- Analytical chemistry and quality research
- Computational chemistry
- Protein science
- NGS and bioinformatics
- Cell biology
- Pre-clinical studies
- Bioanalysis
- Biological evaluation
- FBDD/SBDD chemistry
- Pre-clinical studies and bioanalysis
- Lead time
- Under two days
Capabilities
As they state on their website or in their listing.
- Processes
- Small molecule
- Peptide
- Oligonucleotide
- Gene editing
- NGS
- Bioanalysis
4 more
- PK/PD
- Toxicology
- CRISPR
- ADME
- Capacity
- >1.2 Trillion DNA encoded compounds
- Over 100,000 kinds of reagents
- Over two hundred professional chemical synthesis personnel
- Over 5,000 square meters laboratory hardware
- 500㎡ BSL-2 laboratories
- 200㎡ BSL-2 laboratories
6 more
- Approximately 300m² BSL-2 cell culture laboratory
- Over 50 different E3 ubiquitin ligases
- More than 40 different target classes
- Mg to g samples
- Over 600 clients globally
- Thousands of drug development projects
- Scales
- Milligram · Gram
- Data supplied
- NMR · LC-MS · HPLC
Equipment
- Illumina NextSeq2000
- Illumina NovaSeq6000
- MGISEQ-2000
- UPLC-MS
- Prep-HPLC
- NMR
11 more
- LC-MS
- GC-MS
- SFC
- HR LC-MS
- High-content imaging system
- Confocal microscope
- Flow cytometer
- Digital dispenser
- Affinity Selection Mass Spectrometry (ASMS)
- HPLC
- Prep-SFC
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Details
- Type
- CRO
- Based in
- Chengdu, China
- Sites
- Cambridge, United Kingdom
- Houston, USA
- Serves
- Global, global pharmaceutical industry